Pharmocogenetics of GABAergic mechanisms of benefit and harm in epilepsy: a cohort and case control study to determine environmental and genetic factors associated with response to clobazam.
Latest Information Update: 06 Sep 2019
At a glance
- Drugs Clobazam (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
- Acronyms Pharmacogenetics:clobazam
- 04 Mar 2010 United Kingdom Clinical Research Network reports accrual to date changed from 86% to 91%.
- 30 Apr 2009 Planned end date changed from 31 Dec 2007 to 1 Aug 2009 as reported by United Kingdom Clinical Research Network.
- 10 Feb 2009 New source identified and integrated (United Kingdom Clinical Research Network record 6334).